EXDI - Exactus, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Exactus, Inc.

80 NE 4th Avenue
Suite 28
Delray Beach, FL 33483
United States

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Vladislav YampolskyInterim Exec. ChairmanN/AN/A1978
Mr. Emiliano Angel AloiInterim CEO & Member of Advisory Board360.08kN/A1974
Mr. Derek Du ChesnePres, Chief Growth Officer & DirectorN/AN/AN/A
Mr. Kenneth E. PuzderCFO & Director162.86kN/A1967
Mr. Andrew L. JohnsonChief Strategy Officer111.57kN/A1985
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Exactus, Inc., a healthcare company, engages in pursuing opportunities in hemp derived Cannabidiol (CBD) products. The company sells its CBD products through its Exactus brand and white label products to third-party resellers. It produces industrial hemp from farms in Oregon, and plans to extract and manufacture directly through cGMP facilities. The company is based in Delray Beach, Florida.

Corporate Governance

Exactus, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.